Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/31840
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_UseRadiofrequencyHepatocellular.pdf483,55 kBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorMonteiro, Melissa Silva-
dc.contributor.authorGuimarães, Guilherme dos Anjos-
dc.contributor.authorMotta, Bruno da Costa-
dc.contributor.authorFonseca, Ronei Delfino da-
dc.contributor.authorMarques, Marina Pinheiro-
dc.contributor.authorMendonça, Gabriel Williams Silva de-
dc.contributor.authorRosa, Suélia de Siqueira Rodrigues Fleury-
dc.date.accessioned2018-05-14T12:08:01Z-
dc.date.available2018-05-14T12:08:01Z-
dc.date.issued2017-07-
dc.identifier.citationMONTEIRO, Melissa Silva et al. The use of radiofrequency for hepatocellular carcinoma ablation: an update review and perspectives. International Journal of Biosensors & Bioelectronics, v. 3, n. 1, p. 1-6, set. 2017. Disponível em: <http://medcraveonline.com/IJBSBE/IJBSBE-03-00055.php>. Acesso em: 9 maio 2018.pt_BR
dc.identifier.urihttp://repositorio.unb.br/handle/10482/31840-
dc.language.isoInglêspt_BR
dc.publisherMedCrave Grouppt_BR
dc.rightsAcesso Abertopt_BR
dc.titleThe use of radiofrequency for hepatocellular carcinoma ablation : an update review and perspectivespt_BR
dc.typeArtigopt_BR
dc.subject.keywordCarcinoma hepatocelularpt_BR
dc.subject.keywordRadiofrequênciapt_BR
dc.subject.keywordNanopartículaspt_BR
dc.rights.licenseOpen Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License (CC BY NC). Fonte: http://medcraveonline.com:/IJBSBE/IJBSBE-03-00055.php. Acesso em: 14 maio 2018.pt_BR
dc.description.abstract1The World Health Organization classifies liver cancer among the five types of cancer with highest death rates in the world. Among the current methods available for the treatment of liver cancer, there is the resection of hepatic tissue and the radiofrequency ablation of the tumor. Even though resection presents the best results, only 10% to 15% of the affected patients may eligible for this procedure. On the other hand, the radiofrequency ablation encompasses a larger scope of patients and provides a non-invasive method when compared to resection. There is research with sufficient evidence to allow the transposition of this concept to new technological paradigms, which would yield a more effective ablation process, i.e.: generating enough volumetric necrosis for complete regression of the tumor, leading to a high survival rate of patients. These technological paradigms encompass aspects of operability, innovation and of theoretical framework. In terms of operability, there is the use of better imaging sources to aid the healthcare professional in the positioning of electrodes; in terms of innovation, there are new technologies such as the use of optical fiber microsensors and metallic magnetic nanoparticles to increase the efficiency of the process; in terms of theoretical framework, there is the development of more precise mathematical models that would expand the possibilities of application and increase its effectiveness. These new challenges are new possibilities that may reshape the concept and the use of radiofrequency ablation as it is currently known.pt_BR
dc.description.unidadeFaculdade UnB Gama (FGA)-
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.